IRIS Accounts Production v25.1.4.42 14543408 Board of Directors 6.4.24 5.4.25 5.4.25 false true false false true false Ordinary 1.00000 15711 11872 27265 52872 30590 25289 12386 15711 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh145434082024-04-05145434082025-04-05145434082024-04-062025-04-05145434082023-04-05145434082023-04-062024-04-05145434082024-04-0514543408ns15:EnglandWales2024-04-062025-04-0514543408ns14:PoundSterling2024-04-062025-04-0514543408ns10:Director12024-04-062025-04-0514543408ns10:PrivateLimitedCompanyLtd2024-04-062025-04-0514543408ns10:SmallEntities2024-04-062025-04-0514543408ns10:AuditExempt-NoAccountantsReport2024-04-062025-04-0514543408ns10:SmallCompaniesRegimeForDirectorsReport2024-04-062025-04-0514543408ns10:SmallCompaniesRegimeForAccounts2024-04-062025-04-0514543408ns10:FullAccounts2024-04-062025-04-0514543408ns10:OrdinaryShareClass12024-04-062025-04-0514543408ns10:Director2422024-04-0514543408ns10:Director2422023-04-0514543408ns10:Director2422024-04-062025-04-0514543408ns10:Director2422023-04-062024-04-0514543408ns10:Director2422025-04-0514543408ns10:Director2422024-04-0514543408ns5:CurrentFinancialInstruments2025-04-0514543408ns5:CurrentFinancialInstruments2024-04-0514543408ns5:ShareCapital2025-04-0514543408ns5:ShareCapital2024-04-0514543408ns5:RetainedEarningsAccumulatedLosses2025-04-0514543408ns5:RetainedEarningsAccumulatedLosses2024-04-0514543408ns10:RegisteredOffice2024-04-062025-04-0514543408ns5:FurnitureFittings2024-04-062025-04-0514543408ns5:FurnitureFittings2024-04-0514543408ns5:FurnitureFittings2025-04-0514543408ns5:FurnitureFittings2024-04-0514543408ns5:WithinOneYearns5:CurrentFinancialInstruments2025-04-0514543408ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-0514543408ns10:OrdinaryShareClass12025-04-0514543408ns10:Director22024-04-062025-04-05145434081ns10:Director12024-04-05145434081ns10:Director12023-04-05145434081ns10:Director12024-04-062025-04-05145434081ns10:Director12023-04-062024-04-05145434081ns10:Director12025-04-05145434081ns10:Director12024-04-05
REGISTERED NUMBER: 14543408 (England and Wales)















Unaudited Financial Statements for the Year Ended 5th April 2025

for

JRS Surgical Ltd

JRS Surgical Ltd (Registered number: 14543408)






Contents of the Financial Statements
for the Year Ended 5th April 2025




Page

Balance Sheet 1

Notes to the Financial Statements 2


JRS Surgical Ltd (Registered number: 14543408)

Balance Sheet
5th April 2025

5.4.25 5.4.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,143 732

CURRENT ASSETS
Debtors 5 20,969 15,711
Investments 6 47,250 47,250
Cash at bank 201,463 84,479
269,682 147,440
CREDITORS
Amounts falling due within one year 7 37,792 32,795
NET CURRENT ASSETS 231,890 114,645
TOTAL ASSETS LESS CURRENT
LIABILITIES

233,033

115,377

PROVISIONS FOR LIABILITIES 217 139
NET ASSETS 232,816 115,238

CAPITAL AND RESERVES
Called up share capital 8 2 2
Retained earnings 232,814 115,236
SHAREHOLDERS' FUNDS 232,816 115,238

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 5th April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 5th April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4th August 2025 and were signed on its behalf by:




Dr J R Sloane - Director


JRS Surgical Ltd (Registered number: 14543408)

Notes to the Financial Statements
for the Year Ended 5th April 2025

1. COMPANY INFORMATION

JRS Surgical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 14543408

Registered office: Second Floor
The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Current asset investment
Current asset investment represent 375 Ordinary shares of £1.00 each in Surrey Implant Services Ltd. As there is no ascertainable market value available, the directors have valued this on a cost basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

JRS Surgical Ltd (Registered number: 14543408)

Notes to the Financial Statements - continued
for the Year Ended 5th April 2025

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 6th April 2024 799
Additions 698
At 5th April 2025 1,497
DEPRECIATION
At 6th April 2024 (67 )
Charge for year 421
At 5th April 2025 354
NET BOOK VALUE
At 5th April 2025 1,143
At 5th April 2024 866

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
5.4.25 5.4.24
£    £   
Other debtors 8,583 -
Directors' current accounts 12,386 15,711
20,969 15,711

6. CURRENT ASSET INVESTMENTS
5.4.25 5.4.24
£    £   
Unlisted investments 47,250 47,250

375 unlisted shares purchased in Surrey Implant Services Ltd.

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
5.4.25 5.4.24
£    £   
Tax 35,885 31,085
Accrued expenses 1,907 1,710
37,792 32,795

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 5.4.25 5.4.24
value: £    £   
2 Ordinary £1 2 2

JRS Surgical Ltd (Registered number: 14543408)

Notes to the Financial Statements - continued
for the Year Ended 5th April 2025

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 5th April 2025 and 5th April 2024:

5.4.25 5.4.24
£    £   
Dr J R Sloane and Mrs E D Sloane
Balance outstanding at start of year 15,711 (11,872 )
Amounts advanced 27,265 52,872
Amounts repaid (30,590 ) (25,289 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 12,386 15,711

The loan is repayable on demand and no interest was charged during the year.

10. ULTIMATE CONTROLLING PARTY

The controlling party is the directors.